nodes	percent_of_prediction	percent_of_DWPC	metapath
Scopolamine—ABCB1—Ethinyl Estradiol—osteoporosis	0.00505	0.42	CbGbCtD
Scopolamine—ABCB1—Conjugated Estrogens—osteoporosis	0.00371	0.309	CbGbCtD
Scopolamine—ABCB1—Estradiol—osteoporosis	0.00325	0.271	CbGbCtD
Scopolamine—Oedema—Estropipate—osteoporosis	0.00204	0.00259	CcSEcCtD
Scopolamine—Mental disorder—Ethinyl Estradiol—osteoporosis	0.00204	0.00259	CcSEcCtD
Scopolamine—Arrhythmia—Risedronate—osteoporosis	0.00203	0.00257	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.00203	0.00257	CcSEcCtD
Scopolamine—Constipation—Etidronic acid—osteoporosis	0.00202	0.00256	CcSEcCtD
Scopolamine—Eye disorder—Pamidronate—osteoporosis	0.00202	0.00256	CcSEcCtD
Scopolamine—Dry skin—Estradiol—osteoporosis	0.00202	0.00255	CcSEcCtD
Scopolamine—Bradycardia—Zoledronate—osteoporosis	0.00201	0.00255	CcSEcCtD
Scopolamine—Flushing—Pamidronate—osteoporosis	0.00201	0.00254	CcSEcCtD
Scopolamine—Nervous system disorder—Estropipate—osteoporosis	0.002	0.00254	CcSEcCtD
Scopolamine—Dry mouth—Ibandronate—osteoporosis	0.002	0.00253	CcSEcCtD
Scopolamine—Mental disorder—Risedronate—osteoporosis	0.00199	0.00252	CcSEcCtD
Scopolamine—Skin disorder—Estropipate—osteoporosis	0.00199	0.00251	CcSEcCtD
Scopolamine—Dry mouth—Calcitriol—osteoporosis	0.00196	0.00248	CcSEcCtD
Scopolamine—Urinary tract disorder—Zoledronate—osteoporosis	0.00195	0.00247	CcSEcCtD
Scopolamine—Feeling abnormal—Etidronic acid—osteoporosis	0.00195	0.00247	CcSEcCtD
Scopolamine—Nervous system disorder—Raloxifene—osteoporosis	0.00194	0.00246	CcSEcCtD
Scopolamine—Urethral disorder—Zoledronate—osteoporosis	0.00193	0.00245	CcSEcCtD
Scopolamine—Skin disorder—Raloxifene—osteoporosis	0.00192	0.00244	CcSEcCtD
Scopolamine—Nervous system disorder—Ibandronate—osteoporosis	0.00192	0.00243	CcSEcCtD
Scopolamine—Hyperhidrosis—Raloxifene—osteoporosis	0.00191	0.00242	CcSEcCtD
Scopolamine—Skin disorder—Ibandronate—osteoporosis	0.0019	0.00241	CcSEcCtD
Scopolamine—Dysphagia—Estradiol—osteoporosis	0.0019	0.00241	CcSEcCtD
Scopolamine—Hyperhidrosis—Ibandronate—osteoporosis	0.00189	0.0024	CcSEcCtD
Scopolamine—Nausea—Ergocalciferol—osteoporosis	0.00189	0.00239	CcSEcCtD
Scopolamine—Pharyngitis—Conjugated Estrogens—osteoporosis	0.00189	0.00239	CcSEcCtD
Scopolamine—Erythema—Pamidronate—osteoporosis	0.00188	0.00238	CcSEcCtD
Scopolamine—Abdominal pain—Etidronic acid—osteoporosis	0.00187	0.00237	CcSEcCtD
Scopolamine—Skin disorder—Calcitriol—osteoporosis	0.00186	0.00236	CcSEcCtD
Scopolamine—Eye disorder—Zoledronate—osteoporosis	0.00184	0.00234	CcSEcCtD
Scopolamine—Flushing—Zoledronate—osteoporosis	0.00183	0.00232	CcSEcCtD
Scopolamine—Visual impairment—Conjugated Estrogens—osteoporosis	0.00183	0.00232	CcSEcCtD
Scopolamine—Somnolence—Estropipate—osteoporosis	0.00182	0.0023	CcSEcCtD
Scopolamine—Vertigo—Risedronate—osteoporosis	0.00178	0.00225	CcSEcCtD
Scopolamine—Eye disorder—Conjugated Estrogens—osteoporosis	0.00178	0.00225	CcSEcCtD
Scopolamine—Arrhythmia—Zoledronate—osteoporosis	0.00176	0.00223	CcSEcCtD
Scopolamine—Fatigue—Estropipate—osteoporosis	0.00176	0.00223	CcSEcCtD
Scopolamine—Pain—Estropipate—osteoporosis	0.00175	0.00221	CcSEcCtD
Scopolamine—Constipation—Estropipate—osteoporosis	0.00175	0.00221	CcSEcCtD
Scopolamine—Mental disorder—Zoledronate—osteoporosis	0.00173	0.00219	CcSEcCtD
Scopolamine—Agitation—Pamidronate—osteoporosis	0.00173	0.00219	CcSEcCtD
Scopolamine—Constipation—Alendronate—osteoporosis	0.00172	0.00218	CcSEcCtD
Scopolamine—Pain—Alendronate—osteoporosis	0.00172	0.00218	CcSEcCtD
Scopolamine—Erythema—Zoledronate—osteoporosis	0.00172	0.00218	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.00172	0.00217	CcSEcCtD
Scopolamine—Somnolence—Calcitriol—osteoporosis	0.00171	0.00216	CcSEcCtD
Scopolamine—Arrhythmia—Conjugated Estrogens—osteoporosis	0.0017	0.00215	CcSEcCtD
Scopolamine—Pain—Raloxifene—osteoporosis	0.00169	0.00214	CcSEcCtD
Scopolamine—Fatigue—Ibandronate—osteoporosis	0.00169	0.00214	CcSEcCtD
Scopolamine—Pain—Ibandronate—osteoporosis	0.00168	0.00212	CcSEcCtD
Scopolamine—Constipation—Ibandronate—osteoporosis	0.00168	0.00212	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.00167	0.00212	CcSEcCtD
Scopolamine—Pruritus—Etidronic acid—osteoporosis	0.00167	0.00212	CcSEcCtD
Scopolamine—Mental disorder—Conjugated Estrogens—osteoporosis	0.00167	0.00211	CcSEcCtD
Scopolamine—Feeling abnormal—Alendronate—osteoporosis	0.00166	0.0021	CcSEcCtD
Scopolamine—Oedema—Ethinyl Estradiol—osteoporosis	0.00166	0.0021	CcSEcCtD
Scopolamine—Erythema—Conjugated Estrogens—osteoporosis	0.00165	0.0021	CcSEcCtD
Scopolamine—Dry mouth—Risedronate—osteoporosis	0.00165	0.00209	CcSEcCtD
Scopolamine—Conjunctivitis—Estradiol—osteoporosis	0.00165	0.00209	CcSEcCtD
Scopolamine—Pain—Calcitriol—osteoporosis	0.00164	0.00208	CcSEcCtD
Scopolamine—Constipation—Calcitriol—osteoporosis	0.00164	0.00208	CcSEcCtD
Scopolamine—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.00162	0.00206	CcSEcCtD
Scopolamine—Vision blurred—Zoledronate—osteoporosis	0.00162	0.00205	CcSEcCtD
Scopolamine—Abdominal pain—Estropipate—osteoporosis	0.00162	0.00205	CcSEcCtD
Scopolamine—Body temperature increased—Estropipate—osteoporosis	0.00162	0.00205	CcSEcCtD
Scopolamine—Feeling abnormal—Ibandronate—osteoporosis	0.00161	0.00205	CcSEcCtD
Scopolamine—Tremor—Zoledronate—osteoporosis	0.00161	0.00204	CcSEcCtD
Scopolamine—Skin disorder—Ethinyl Estradiol—osteoporosis	0.00161	0.00204	CcSEcCtD
Scopolamine—Abdominal pain—Alendronate—osteoporosis	0.00159	0.00202	CcSEcCtD
Scopolamine—Body temperature increased—Alendronate—osteoporosis	0.00159	0.00202	CcSEcCtD
Scopolamine—Nervous system disorder—Risedronate—osteoporosis	0.00158	0.00201	CcSEcCtD
Scopolamine—Agitation—Zoledronate—osteoporosis	0.00158	0.002	CcSEcCtD
Scopolamine—Skin disorder—Risedronate—osteoporosis	0.00157	0.00199	CcSEcCtD
Scopolamine—Body temperature increased—Raloxifene—osteoporosis	0.00156	0.00198	CcSEcCtD
Scopolamine—Abdominal pain—Raloxifene—osteoporosis	0.00156	0.00198	CcSEcCtD
Scopolamine—Vision blurred—Conjugated Estrogens—osteoporosis	0.00156	0.00198	CcSEcCtD
Scopolamine—Body temperature increased—Ibandronate—osteoporosis	0.00155	0.00196	CcSEcCtD
Scopolamine—Abdominal pain—Ibandronate—osteoporosis	0.00155	0.00196	CcSEcCtD
Scopolamine—Confusional state—Pamidronate—osteoporosis	0.00155	0.00196	CcSEcCtD
Scopolamine—Vertigo—Zoledronate—osteoporosis	0.00154	0.00196	CcSEcCtD
Scopolamine—Oedema—Pamidronate—osteoporosis	0.00154	0.00194	CcSEcCtD
Scopolamine—Abdominal pain—Calcitriol—osteoporosis	0.00152	0.00192	CcSEcCtD
Scopolamine—Body temperature increased—Calcitriol—osteoporosis	0.00152	0.00192	CcSEcCtD
Scopolamine—Pharyngitis—Estradiol—osteoporosis	0.00151	0.00191	CcSEcCtD
Scopolamine—Nervous system disorder—Pamidronate—osteoporosis	0.00151	0.00191	CcSEcCtD
Scopolamine—Urinary tract disorder—Estradiol—osteoporosis	0.0015	0.0019	CcSEcCtD
Scopolamine—Vomiting—Etidronic acid—osteoporosis	0.0015	0.0019	CcSEcCtD
Scopolamine—Tachycardia—Pamidronate—osteoporosis	0.0015	0.0019	CcSEcCtD
Scopolamine—Urethral disorder—Estradiol—osteoporosis	0.00149	0.00189	CcSEcCtD
Scopolamine—Rash—Etidronic acid—osteoporosis	0.00149	0.00189	CcSEcCtD
Scopolamine—Dermatitis—Etidronic acid—osteoporosis	0.00149	0.00189	CcSEcCtD
Scopolamine—Vertigo—Conjugated Estrogens—osteoporosis	0.00149	0.00188	CcSEcCtD
Scopolamine—Hyperhidrosis—Pamidronate—osteoporosis	0.00148	0.00188	CcSEcCtD
Scopolamine—Headache—Etidronic acid—osteoporosis	0.00148	0.00187	CcSEcCtD
Scopolamine—Asthenia—Estropipate—osteoporosis	0.00147	0.00186	CcSEcCtD
Scopolamine—Visual impairment—Estradiol—osteoporosis	0.00147	0.00186	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.00145	0.00184	CcSEcCtD
Scopolamine—Pruritus—Estropipate—osteoporosis	0.00145	0.00183	CcSEcCtD
Scopolamine—Asthenia—Alendronate—osteoporosis	0.00144	0.00183	CcSEcCtD
Scopolamine—Hypotension—Pamidronate—osteoporosis	0.00143	0.00182	CcSEcCtD
Scopolamine—Dry mouth—Zoledronate—osteoporosis	0.00143	0.00181	CcSEcCtD
Scopolamine—Fatigue—Ethinyl Estradiol—osteoporosis	0.00143	0.00181	CcSEcCtD
Scopolamine—Pruritus—Alendronate—osteoporosis	0.00142	0.0018	CcSEcCtD
Scopolamine—Eye disorder—Estradiol—osteoporosis	0.00142	0.0018	CcSEcCtD
Scopolamine—Constipation—Ethinyl Estradiol—osteoporosis	0.00142	0.00179	CcSEcCtD
Scopolamine—Confusional state—Zoledronate—osteoporosis	0.00141	0.00179	CcSEcCtD
Scopolamine—Flushing—Estradiol—osteoporosis	0.00141	0.00179	CcSEcCtD
Scopolamine—Asthenia—Ibandronate—osteoporosis	0.00141	0.00178	CcSEcCtD
Scopolamine—Nausea—Etidronic acid—osteoporosis	0.0014	0.00178	CcSEcCtD
Scopolamine—Oedema—Zoledronate—osteoporosis	0.0014	0.00178	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.0014	0.00177	CcSEcCtD
Scopolamine—Fatigue—Risedronate—osteoporosis	0.00139	0.00176	CcSEcCtD
Scopolamine—Pruritus—Ibandronate—osteoporosis	0.00139	0.00176	CcSEcCtD
Scopolamine—Pain—Risedronate—osteoporosis	0.00138	0.00175	CcSEcCtD
Scopolamine—Constipation—Risedronate—osteoporosis	0.00138	0.00175	CcSEcCtD
Scopolamine—Asthenia—Calcitriol—osteoporosis	0.00138	0.00174	CcSEcCtD
Scopolamine—Nervous system disorder—Zoledronate—osteoporosis	0.00138	0.00174	CcSEcCtD
Scopolamine—Tachycardia—Zoledronate—osteoporosis	0.00137	0.00173	CcSEcCtD
Scopolamine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.00137	0.00173	CcSEcCtD
Scopolamine—Somnolence—Pamidronate—osteoporosis	0.00136	0.00173	CcSEcCtD
Scopolamine—Skin disorder—Zoledronate—osteoporosis	0.00136	0.00173	CcSEcCtD
Scopolamine—Pruritus—Calcitriol—osteoporosis	0.00136	0.00172	CcSEcCtD
Scopolamine—Hyperhidrosis—Zoledronate—osteoporosis	0.00136	0.00172	CcSEcCtD
Scopolamine—Dizziness—Estropipate—osteoporosis	0.00135	0.00171	CcSEcCtD
Scopolamine—Oedema—Conjugated Estrogens—osteoporosis	0.00135	0.00171	CcSEcCtD
Scopolamine—Mental disorder—Estradiol—osteoporosis	0.00133	0.00169	CcSEcCtD
Scopolamine—Dizziness—Alendronate—osteoporosis	0.00133	0.00169	CcSEcCtD
Scopolamine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00132	0.00168	CcSEcCtD
Scopolamine—Erythema—Estradiol—osteoporosis	0.00132	0.00168	CcSEcCtD
Scopolamine—Fatigue—Pamidronate—osteoporosis	0.00132	0.00168	CcSEcCtD
Scopolamine—Tachycardia—Conjugated Estrogens—osteoporosis	0.00132	0.00167	CcSEcCtD
Scopolamine—Pain—Pamidronate—osteoporosis	0.00131	0.00166	CcSEcCtD
Scopolamine—Constipation—Pamidronate—osteoporosis	0.00131	0.00166	CcSEcCtD
Scopolamine—Skin disorder—Conjugated Estrogens—osteoporosis	0.00131	0.00166	CcSEcCtD
Scopolamine—Hypotension—Zoledronate—osteoporosis	0.00131	0.00166	CcSEcCtD
Scopolamine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00131	0.00166	CcSEcCtD
Scopolamine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00131	0.00166	CcSEcCtD
Scopolamine—Dizziness—Raloxifene—osteoporosis	0.00131	0.00166	CcSEcCtD
Scopolamine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.00131	0.00165	CcSEcCtD
Scopolamine—Vomiting—Estropipate—osteoporosis	0.0013	0.00165	CcSEcCtD
Scopolamine—Dizziness—Ibandronate—osteoporosis	0.0013	0.00164	CcSEcCtD
Scopolamine—Rash—Estropipate—osteoporosis	0.00129	0.00163	CcSEcCtD
Scopolamine—Dermatitis—Estropipate—osteoporosis	0.00129	0.00163	CcSEcCtD
Scopolamine—Headache—Estropipate—osteoporosis	0.00128	0.00162	CcSEcCtD
Scopolamine—Vomiting—Alendronate—osteoporosis	0.00128	0.00162	CcSEcCtD
Scopolamine—Abdominal pain—Risedronate—osteoporosis	0.00128	0.00162	CcSEcCtD
Scopolamine—Body temperature increased—Risedronate—osteoporosis	0.00128	0.00162	CcSEcCtD
Scopolamine—Rash—Alendronate—osteoporosis	0.00127	0.00161	CcSEcCtD
Scopolamine—Dermatitis—Alendronate—osteoporosis	0.00127	0.00161	CcSEcCtD
Scopolamine—Feeling abnormal—Pamidronate—osteoporosis	0.00127	0.0016	CcSEcCtD
Scopolamine—Hypotension—Conjugated Estrogens—osteoporosis	0.00126	0.0016	CcSEcCtD
Scopolamine—Headache—Alendronate—osteoporosis	0.00126	0.0016	CcSEcCtD
Scopolamine—Vomiting—Raloxifene—osteoporosis	0.00126	0.00159	CcSEcCtD
Scopolamine—Rash—Raloxifene—osteoporosis	0.00125	0.00158	CcSEcCtD
Scopolamine—Dermatitis—Raloxifene—osteoporosis	0.00125	0.00158	CcSEcCtD
Scopolamine—Somnolence—Zoledronate—osteoporosis	0.00125	0.00158	CcSEcCtD
Scopolamine—Vomiting—Ibandronate—osteoporosis	0.00125	0.00158	CcSEcCtD
Scopolamine—Tremor—Estradiol—osteoporosis	0.00124	0.00157	CcSEcCtD
Scopolamine—Headache—Raloxifene—osteoporosis	0.00124	0.00157	CcSEcCtD
Scopolamine—Rash—Ibandronate—osteoporosis	0.00124	0.00157	CcSEcCtD
Scopolamine—Dermatitis—Ibandronate—osteoporosis	0.00123	0.00156	CcSEcCtD
Scopolamine—Headache—Ibandronate—osteoporosis	0.00123	0.00156	CcSEcCtD
Scopolamine—Vomiting—Calcitriol—osteoporosis	0.00122	0.00155	CcSEcCtD
Scopolamine—Agitation—Estradiol—osteoporosis	0.00122	0.00154	CcSEcCtD
Scopolamine—Nausea—Estropipate—osteoporosis	0.00121	0.00154	CcSEcCtD
Scopolamine—Body temperature increased—Pamidronate—osteoporosis	0.00121	0.00154	CcSEcCtD
Scopolamine—Abdominal pain—Pamidronate—osteoporosis	0.00121	0.00154	CcSEcCtD
Scopolamine—Rash—Calcitriol—osteoporosis	0.00121	0.00153	CcSEcCtD
Scopolamine—Fatigue—Zoledronate—osteoporosis	0.00121	0.00153	CcSEcCtD
Scopolamine—Dermatitis—Calcitriol—osteoporosis	0.00121	0.00153	CcSEcCtD
Scopolamine—Headache—Calcitriol—osteoporosis	0.0012	0.00152	CcSEcCtD
Scopolamine—Somnolence—Conjugated Estrogens—osteoporosis	0.0012	0.00152	CcSEcCtD
Scopolamine—Pain—Zoledronate—osteoporosis	0.0012	0.00152	CcSEcCtD
Scopolamine—Constipation—Zoledronate—osteoporosis	0.0012	0.00152	CcSEcCtD
Scopolamine—Nausea—Alendronate—osteoporosis	0.0012	0.00151	CcSEcCtD
Scopolamine—Vertigo—Estradiol—osteoporosis	0.00119	0.00151	CcSEcCtD
Scopolamine—Asthenia—Ethinyl Estradiol—osteoporosis	0.00119	0.00151	CcSEcCtD
Scopolamine—Nausea—Raloxifene—osteoporosis	0.00118	0.00149	CcSEcCtD
Scopolamine—Pruritus—Ethinyl Estradiol—osteoporosis	0.00117	0.00148	CcSEcCtD
Scopolamine—Fatigue—Conjugated Estrogens—osteoporosis	0.00116	0.00147	CcSEcCtD
Scopolamine—Nausea—Ibandronate—osteoporosis	0.00116	0.00147	CcSEcCtD
Scopolamine—Asthenia—Risedronate—osteoporosis	0.00116	0.00147	CcSEcCtD
Scopolamine—Feeling abnormal—Zoledronate—osteoporosis	0.00116	0.00146	CcSEcCtD
Scopolamine—Constipation—Conjugated Estrogens—osteoporosis	0.00115	0.00146	CcSEcCtD
Scopolamine—Pain—Conjugated Estrogens—osteoporosis	0.00115	0.00146	CcSEcCtD
Scopolamine—Pruritus—Risedronate—osteoporosis	0.00114	0.00145	CcSEcCtD
Scopolamine—Nausea—Calcitriol—osteoporosis	0.00114	0.00144	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.00112	0.00142	CcSEcCtD
Scopolamine—Abdominal pain—Zoledronate—osteoporosis	0.00111	0.0014	CcSEcCtD
Scopolamine—Body temperature increased—Zoledronate—osteoporosis	0.00111	0.0014	CcSEcCtD
Scopolamine—Dry mouth—Estradiol—osteoporosis	0.0011	0.0014	CcSEcCtD
Scopolamine—Asthenia—Pamidronate—osteoporosis	0.0011	0.0014	CcSEcCtD
Scopolamine—Dizziness—Ethinyl Estradiol—osteoporosis	0.0011	0.00139	CcSEcCtD
Scopolamine—Confusional state—Estradiol—osteoporosis	0.00109	0.00138	CcSEcCtD
Scopolamine—Pruritus—Pamidronate—osteoporosis	0.00109	0.00138	CcSEcCtD
Scopolamine—Oedema—Estradiol—osteoporosis	0.00108	0.00137	CcSEcCtD
Scopolamine—Dizziness—Risedronate—osteoporosis	0.00107	0.00135	CcSEcCtD
Scopolamine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.00107	0.00135	CcSEcCtD
Scopolamine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.00107	0.00135	CcSEcCtD
Scopolamine—Nervous system disorder—Estradiol—osteoporosis	0.00106	0.00134	CcSEcCtD
Scopolamine—Tachycardia—Estradiol—osteoporosis	0.00105	0.00134	CcSEcCtD
Scopolamine—Vomiting—Ethinyl Estradiol—osteoporosis	0.00105	0.00133	CcSEcCtD
Scopolamine—Skin disorder—Estradiol—osteoporosis	0.00105	0.00133	CcSEcCtD
Scopolamine—Hyperhidrosis—Estradiol—osteoporosis	0.00104	0.00132	CcSEcCtD
Scopolamine—Rash—Ethinyl Estradiol—osteoporosis	0.00104	0.00132	CcSEcCtD
Scopolamine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00104	0.00132	CcSEcCtD
Scopolamine—Headache—Ethinyl Estradiol—osteoporosis	0.00104	0.00131	CcSEcCtD
Scopolamine—Vomiting—Risedronate—osteoporosis	0.00103	0.0013	CcSEcCtD
Scopolamine—Rash—Risedronate—osteoporosis	0.00102	0.00129	CcSEcCtD
Scopolamine—Dermatitis—Risedronate—osteoporosis	0.00102	0.00129	CcSEcCtD
Scopolamine—Dizziness—Pamidronate—osteoporosis	0.00102	0.00129	CcSEcCtD
Scopolamine—Headache—Risedronate—osteoporosis	0.00101	0.00128	CcSEcCtD
Scopolamine—Asthenia—Zoledronate—osteoporosis	0.00101	0.00127	CcSEcCtD
Scopolamine—Pruritus—Zoledronate—osteoporosis	0.000992	0.00126	CcSEcCtD
Scopolamine—Nausea—Ethinyl Estradiol—osteoporosis	0.000984	0.00125	CcSEcCtD
Scopolamine—Vomiting—Pamidronate—osteoporosis	0.000976	0.00124	CcSEcCtD
Scopolamine—Asthenia—Conjugated Estrogens—osteoporosis	0.000969	0.00123	CcSEcCtD
Scopolamine—Rash—Pamidronate—osteoporosis	0.000968	0.00123	CcSEcCtD
Scopolamine—Dermatitis—Pamidronate—osteoporosis	0.000967	0.00123	CcSEcCtD
Scopolamine—Headache—Pamidronate—osteoporosis	0.000962	0.00122	CcSEcCtD
Scopolamine—Somnolence—Estradiol—osteoporosis	0.000961	0.00122	CcSEcCtD
Scopolamine—Nausea—Risedronate—osteoporosis	0.000959	0.00122	CcSEcCtD
Scopolamine—Pruritus—Conjugated Estrogens—osteoporosis	0.000955	0.00121	CcSEcCtD
Scopolamine—Fatigue—Estradiol—osteoporosis	0.000932	0.00118	CcSEcCtD
Scopolamine—Dizziness—Zoledronate—osteoporosis	0.000927	0.00117	CcSEcCtD
Scopolamine—Pain—Estradiol—osteoporosis	0.000924	0.00117	CcSEcCtD
Scopolamine—Constipation—Estradiol—osteoporosis	0.000924	0.00117	CcSEcCtD
Scopolamine—Nausea—Pamidronate—osteoporosis	0.000912	0.00116	CcSEcCtD
Scopolamine—Dizziness—Conjugated Estrogens—osteoporosis	0.000893	0.00113	CcSEcCtD
Scopolamine—Vomiting—Zoledronate—osteoporosis	0.000892	0.00113	CcSEcCtD
Scopolamine—Feeling abnormal—Estradiol—osteoporosis	0.000891	0.00113	CcSEcCtD
Scopolamine—Rash—Zoledronate—osteoporosis	0.000884	0.00112	CcSEcCtD
Scopolamine—Dermatitis—Zoledronate—osteoporosis	0.000883	0.00112	CcSEcCtD
Scopolamine—Headache—Zoledronate—osteoporosis	0.000879	0.00111	CcSEcCtD
Scopolamine—Vomiting—Conjugated Estrogens—osteoporosis	0.000859	0.00109	CcSEcCtD
Scopolamine—Body temperature increased—Estradiol—osteoporosis	0.000854	0.00108	CcSEcCtD
Scopolamine—Abdominal pain—Estradiol—osteoporosis	0.000854	0.00108	CcSEcCtD
Scopolamine—Rash—Conjugated Estrogens—osteoporosis	0.000851	0.00108	CcSEcCtD
Scopolamine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000851	0.00108	CcSEcCtD
Scopolamine—Headache—Conjugated Estrogens—osteoporosis	0.000846	0.00107	CcSEcCtD
Scopolamine—Nausea—Zoledronate—osteoporosis	0.000833	0.00106	CcSEcCtD
Scopolamine—Nausea—Conjugated Estrogens—osteoporosis	0.000802	0.00102	CcSEcCtD
Scopolamine—Asthenia—Estradiol—osteoporosis	0.000775	0.000982	CcSEcCtD
Scopolamine—Pruritus—Estradiol—osteoporosis	0.000765	0.000969	CcSEcCtD
Scopolamine—Dizziness—Estradiol—osteoporosis	0.000715	0.000905	CcSEcCtD
Scopolamine—Vomiting—Estradiol—osteoporosis	0.000687	0.000871	CcSEcCtD
Scopolamine—Rash—Estradiol—osteoporosis	0.000681	0.000863	CcSEcCtD
Scopolamine—Dermatitis—Estradiol—osteoporosis	0.000681	0.000862	CcSEcCtD
Scopolamine—Headache—Estradiol—osteoporosis	0.000677	0.000858	CcSEcCtD
Scopolamine—Nausea—Estradiol—osteoporosis	0.000642	0.000813	CcSEcCtD
Scopolamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000167	0.000841	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—CNR2—osteoporosis	0.000167	0.00084	CbGpPWpGaD
Scopolamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000166	0.000833	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—CNR2—osteoporosis	0.000165	0.000831	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PKM—osteoporosis	0.000161	0.000813	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—FDPS—osteoporosis	0.000161	0.000813	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—WNT1—osteoporosis	0.000157	0.000792	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—WNT1—osteoporosis	0.000157	0.000789	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—PTHLH—osteoporosis	0.000157	0.000789	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—PTHLH—osteoporosis	0.000156	0.000786	CbGpPWpGaD
Scopolamine—CHRM2—SIDS Susceptibility Pathways—TNF—osteoporosis	0.000156	0.000783	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—IDH2—osteoporosis	0.000155	0.000783	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—WNT1—osteoporosis	0.000155	0.000782	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—PTHLH—osteoporosis	0.000155	0.000779	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—P4HB—osteoporosis	0.000155	0.000778	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MGLL—osteoporosis	0.000153	0.000772	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GPD2—osteoporosis	0.000153	0.000771	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PGLS—osteoporosis	0.000153	0.000771	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MGLL—osteoporosis	0.000153	0.00077	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	0.000151	0.000762	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MGLL—osteoporosis	0.000151	0.000762	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PTH—osteoporosis	0.00015	0.000757	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—LRP5—osteoporosis	0.00015	0.000754	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—LRP5—osteoporosis	0.000149	0.000751	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—P4HB—osteoporosis	0.000148	0.000745	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—RAP1A—osteoporosis	0.000148	0.000744	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—LRP5—osteoporosis	0.000148	0.000744	CbGpPWpGaD
Scopolamine—SI—Disease—IL6—osteoporosis	0.000148	0.000744	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CNR2—osteoporosis	0.000147	0.000738	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—CYP27A1—osteoporosis	0.000146	0.000736	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—ADCY5—osteoporosis	0.000145	0.000732	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—NFATC1—osteoporosis	0.000144	0.000726	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PTH—osteoporosis	0.000144	0.000725	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—LRP6—osteoporosis	0.000143	0.000721	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—DKK1—osteoporosis	0.000143	0.00072	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—LRP6—osteoporosis	0.000143	0.000719	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—PTHLH—osteoporosis	0.000142	0.000716	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—ACP5—osteoporosis	0.000142	0.000716	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—PTHLH—osteoporosis	0.000142	0.000714	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—RAP1A—osteoporosis	0.000142	0.000713	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—LRP6—osteoporosis	0.000141	0.000712	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—PTHLH—osteoporosis	0.00014	0.000707	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CNR2—osteoporosis	0.00014	0.000707	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PNP—osteoporosis	0.00014	0.000705	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—ATIC—osteoporosis	0.00014	0.000705	CbGpPWpGaD
Scopolamine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	0.00014	0.000704	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—ADCY5—osteoporosis	0.000139	0.000701	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—NFATC1—osteoporosis	0.000138	0.000695	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—CALCA—osteoporosis	0.000138	0.000694	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—WNT1—osteoporosis	0.000138	0.000694	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—CALCA—osteoporosis	0.000137	0.000692	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—DKK1—osteoporosis	0.000137	0.00069	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—CALCA—osteoporosis	0.000136	0.000685	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—FGA—osteoporosis	0.000134	0.000675	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—TPI1—osteoporosis	0.000132	0.000666	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—ADCY5—osteoporosis	0.000132	0.000665	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—WNT1—osteoporosis	0.000132	0.000664	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—FGA—osteoporosis	0.000128	0.000646	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—POMC—osteoporosis	0.000128	0.000643	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—POMC—osteoporosis	0.000127	0.000641	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—ADCY5—osteoporosis	0.000127	0.000637	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—POMC—osteoporosis	0.000126	0.000635	CbGpPWpGaD
Scopolamine—CHRM2—SIDS Susceptibility Pathways—IL6—osteoporosis	0.000126	0.000632	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—CALCA—osteoporosis	0.000125	0.000631	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—CALCA—osteoporosis	0.000125	0.000629	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PTHLH—osteoporosis	0.000125	0.000627	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—BMP2—osteoporosis	0.000125	0.000627	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—P4HB—osteoporosis	0.000124	0.000626	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—CALCA—osteoporosis	0.000124	0.000622	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—GAPDH—osteoporosis	0.000122	0.000614	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—FGB—osteoporosis	0.000122	0.000614	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TLN1—osteoporosis	0.000121	0.000609	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TLN1—osteoporosis	0.000121	0.000607	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PTHLH—osteoporosis	0.000119	0.000601	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—BMP2—osteoporosis	0.000119	0.000601	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TLN1—osteoporosis	0.000119	0.000601	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CA2—osteoporosis	0.000119	0.000599	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—OXCT1—osteoporosis	0.000119	0.000599	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—RAP1A—osteoporosis	0.000119	0.000598	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PSMA2—osteoporosis	0.000118	0.000593	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PSMA5—osteoporosis	0.000118	0.000593	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—FGB—osteoporosis	0.000117	0.000588	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—MGLL—osteoporosis	0.000116	0.000584	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PSMA5—osteoporosis	0.000113	0.000568	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PSMA2—osteoporosis	0.000113	0.000568	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CALCA—osteoporosis	0.00011	0.000552	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—POMC—osteoporosis	0.000107	0.000539	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CALCA—osteoporosis	0.000105	0.000529	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—P4HB—osteoporosis	0.000104	0.000525	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—P4HB—osteoporosis	0.000104	0.000523	CbGpPWpGaD
Scopolamine—CHRM1—Circadian rythm related genes—IL6—osteoporosis	0.000104	0.000523	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—P4HB—osteoporosis	0.000103	0.000518	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—POMC—osteoporosis	0.000102	0.000516	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PTH—osteoporosis	0.000101	0.000511	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PTH—osteoporosis	0.000101	0.000509	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PTH—osteoporosis	0.0001	0.000504	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—RAP1A—osteoporosis	9.97e-05	0.000502	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—KL—osteoporosis	9.96e-05	0.000502	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—RAP1A—osteoporosis	9.94e-05	0.0005	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CNR2—osteoporosis	9.88e-05	0.000498	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—IDH2—osteoporosis	9.86e-05	0.000497	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CNR2—osteoporosis	9.85e-05	0.000496	CbGpPWpGaD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	9.84e-05	0.000495	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—RAP1A—osteoporosis	9.84e-05	0.000495	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—ADCY5—osteoporosis	9.81e-05	0.000494	CbGpPWpGaD
Scopolamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	9.81e-05	0.000494	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—ADCY5—osteoporosis	9.78e-05	0.000492	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CNR2—osteoporosis	9.76e-05	0.000491	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NFATC1—osteoporosis	9.72e-05	0.00049	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—POMC—osteoporosis	9.72e-05	0.000489	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NFATC1—osteoporosis	9.69e-05	0.000488	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—ADCY5—osteoporosis	9.68e-05	0.000488	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—DKK1—osteoporosis	9.65e-05	0.000486	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—DKK1—osteoporosis	9.62e-05	0.000484	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—ENO1—osteoporosis	9.6e-05	0.000484	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NFATC1—osteoporosis	9.6e-05	0.000483	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—KL—osteoporosis	9.54e-05	0.00048	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—DKK1—osteoporosis	9.52e-05	0.000479	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—IL6R—osteoporosis	9.48e-05	0.000477	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PSMA5—osteoporosis	9.46e-05	0.000476	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PSMA2—osteoporosis	9.46e-05	0.000476	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—POMC—osteoporosis	9.31e-05	0.000469	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—WNT1—osteoporosis	9.29e-05	0.000468	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CYP27A1—osteoporosis	9.27e-05	0.000467	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—WNT1—osteoporosis	9.26e-05	0.000466	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—WNT1—osteoporosis	9.17e-05	0.000462	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	9.1e-05	0.000458	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	9.08e-05	0.000457	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—IL6R—osteoporosis	9.08e-05	0.000457	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—FGA—osteoporosis	9.04e-05	0.000455	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—ACP5—osteoporosis	9.02e-05	0.000454	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—FGA—osteoporosis	9.01e-05	0.000454	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—FGA—osteoporosis	8.92e-05	0.000449	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—ADCY5—osteoporosis	8.91e-05	0.000449	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—ADCY5—osteoporosis	8.88e-05	0.000447	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—ADCY5—osteoporosis	8.79e-05	0.000443	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	8.5e-05	0.000428	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	8.48e-05	0.000427	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PTHLH—osteoporosis	8.4e-05	0.000423	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—BMP2—osteoporosis	8.4e-05	0.000423	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—TPI1—osteoporosis	8.39e-05	0.000422	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PTHLH—osteoporosis	8.38e-05	0.000422	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—BMP2—osteoporosis	8.38e-05	0.000422	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PTHLH—osteoporosis	8.3e-05	0.000418	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—BMP2—osteoporosis	8.3e-05	0.000418	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—FGB—osteoporosis	8.22e-05	0.000414	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—FGB—osteoporosis	8.2e-05	0.000413	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—FGB—osteoporosis	8.12e-05	0.000409	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PSMA2—osteoporosis	7.94e-05	0.0004	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PSMA5—osteoporosis	7.94e-05	0.0004	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PSMA5—osteoporosis	7.91e-05	0.000398	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PSMA2—osteoporosis	7.91e-05	0.000398	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—P4HB—osteoporosis	7.89e-05	0.000397	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PSMA5—osteoporosis	7.84e-05	0.000395	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PSMA2—osteoporosis	7.84e-05	0.000395	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—ADCY5—osteoporosis	7.8e-05	0.000393	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GAPDH—osteoporosis	7.74e-05	0.00039	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—CYP19A1—osteoporosis	7.68e-05	0.000387	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—SPP1—osteoporosis	7.55e-05	0.00038	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—RAP1A—osteoporosis	7.54e-05	0.00038	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—ADCY5—osteoporosis	7.47e-05	0.000376	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CALCA—osteoporosis	7.4e-05	0.000372	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CALCA—osteoporosis	7.37e-05	0.000371	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CALCA—osteoporosis	7.3e-05	0.000368	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—SPP1—osteoporosis	7.23e-05	0.000364	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—POMC—osteoporosis	7.22e-05	0.000363	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—POMC—osteoporosis	7.19e-05	0.000362	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—POMC—osteoporosis	7.12e-05	0.000359	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IRS2—osteoporosis	6.83e-05	0.000344	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—KL—osteoporosis	6.72e-05	0.000338	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—KL—osteoporosis	6.7e-05	0.000337	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—LEP—osteoporosis	6.68e-05	0.000336	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—KL—osteoporosis	6.63e-05	0.000334	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—POMC—osteoporosis	6.55e-05	0.00033	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IRS2—osteoporosis	6.54e-05	0.000329	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—POMC—osteoporosis	6.53e-05	0.000329	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—POMC—osteoporosis	6.47e-05	0.000326	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—LEP—osteoporosis	6.4e-05	0.000322	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—IL6R—osteoporosis	6.39e-05	0.000322	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—ESR1—osteoporosis	6.38e-05	0.000321	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—IL6R—osteoporosis	6.37e-05	0.000321	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—IL6R—osteoporosis	6.31e-05	0.000318	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—ADCY5—osteoporosis	6.27e-05	0.000316	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—GPX1—osteoporosis	6.25e-05	0.000315	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—ESR1—osteoporosis	6.11e-05	0.000308	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—ENO1—osteoporosis	6.09e-05	0.000307	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PSMA2—osteoporosis	6.01e-05	0.000302	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PSMA5—osteoporosis	6.01e-05	0.000302	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IRS1—osteoporosis	5.96e-05	0.0003	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—MTHFR—osteoporosis	5.77e-05	0.00029	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—POMC—osteoporosis	5.74e-05	0.000289	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IRS1—osteoporosis	5.71e-05	0.000287	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IL6R—osteoporosis	5.6e-05	0.000282	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IGF1—osteoporosis	5.52e-05	0.000278	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—POMC—osteoporosis	5.5e-05	0.000277	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IL6R—osteoporosis	5.36e-05	0.00027	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IGF1—osteoporosis	5.29e-05	0.000266	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—ADCY5—osteoporosis	5.26e-05	0.000265	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—ADCY5—osteoporosis	5.25e-05	0.000264	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—ADCY5—osteoporosis	5.19e-05	0.000262	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—SPP1—osteoporosis	5.09e-05	0.000256	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—SPP1—osteoporosis	5.08e-05	0.000256	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—SPP1—osteoporosis	5.03e-05	0.000253	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CYP19A1—osteoporosis	4.87e-05	0.000245	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—POMC—osteoporosis	4.61e-05	0.000232	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IRS2—osteoporosis	4.6e-05	0.000232	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IRS2—osteoporosis	4.59e-05	0.000231	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IRS2—osteoporosis	4.55e-05	0.000229	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—LEP—osteoporosis	4.51e-05	0.000227	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—LEP—osteoporosis	4.49e-05	0.000226	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—LEP—osteoporosis	4.45e-05	0.000224	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—ESR1—osteoporosis	4.3e-05	0.000217	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—ESR1—osteoporosis	4.29e-05	0.000216	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—ESR1—osteoporosis	4.25e-05	0.000214	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—IL6—osteoporosis	4.22e-05	0.000213	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—IL6—osteoporosis	4.04e-05	0.000204	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IRS1—osteoporosis	4.02e-05	0.000202	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IRS1—osteoporosis	4.01e-05	0.000202	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—ADCY5—osteoporosis	3.98e-05	0.0002	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IRS1—osteoporosis	3.97e-05	0.0002	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GPX1—osteoporosis	3.97e-05	0.0002	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—POMC—osteoporosis	3.87e-05	0.000195	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—POMC—osteoporosis	3.86e-05	0.000194	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—POMC—osteoporosis	3.82e-05	0.000192	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IL6R—osteoporosis	3.78e-05	0.00019	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IL6R—osteoporosis	3.76e-05	0.000189	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IL6R—osteoporosis	3.73e-05	0.000188	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IGF1—osteoporosis	3.72e-05	0.000187	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IGF1—osteoporosis	3.71e-05	0.000187	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IGF1—osteoporosis	3.68e-05	0.000185	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—MTHFR—osteoporosis	3.66e-05	0.000184	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MYC—osteoporosis	3.32e-05	0.000167	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TGFB1—osteoporosis	3.31e-05	0.000167	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MYC—osteoporosis	3.18e-05	0.00016	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TGFB1—osteoporosis	3.17e-05	0.00016	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—POMC—osteoporosis	2.93e-05	0.000147	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—IL6—osteoporosis	2.85e-05	0.000143	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—IL6—osteoporosis	2.84e-05	0.000143	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—IL6—osteoporosis	2.81e-05	0.000142	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IL6—osteoporosis	2.49e-05	0.000126	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IL6—osteoporosis	2.39e-05	0.00012	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MYC—osteoporosis	2.24e-05	0.000113	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TGFB1—osteoporosis	2.23e-05	0.000112	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MYC—osteoporosis	2.23e-05	0.000112	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TGFB1—osteoporosis	2.23e-05	0.000112	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MYC—osteoporosis	2.21e-05	0.000111	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TGFB1—osteoporosis	2.2e-05	0.000111	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IL6—osteoporosis	1.68e-05	8.47e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IL6—osteoporosis	1.68e-05	8.44e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IL6—osteoporosis	1.66e-05	8.36e-05	CbGpPWpGaD
